Back to Search
Start Over
Alterations of Cardiac ERK1/2 Expression and Activity Due to Volume Overload Were Attenuated by the Blockade of RAS
- Source :
- Journal of Cardiovascular Pharmacology and Therapeutics. 15:84-92
- Publication Year :
- 2010
- Publisher :
- SAGE Publications, 2010.
-
Abstract
- The activities and protein content of extracellular signal-regulated kinase (ERK)1/2 in the heart were measured in rats at 4 and 16 weeks after volume overload due to aortocaval shunt. Protein content of phosphorylated ERK1/2 was increased at both 4 and 16 weeks, whereas protein content of total ERK1/2 was increased only at 16 weeks of inducing volume overload. The ERK1/2 activities, estimated as phospho-Elk-1 content, were also increased at 4 and 16 weeks of inducing volume overload. The increased phosphorylated ERK1/2 and E-26-like (Elk)-1 protein content in 16 weeks failing hearts was much greater than that in 4 weeks hypertrophied hearts. These changes in phosphorylated ERK1/2 and Elk-1 protein content in both 4 and 16 weeks volume overloaded animals were attenuated by treatment with enalapril and/or losartan. The results indicate that activation of ERK1/2 may be involved in the development of cardiac hypertrophy and heart failure due to volume overload, and these changes are partially prevented by blockade of the renin—angiotensin system (RAS).
- Subjects :
- MAPK/ERK pathway
medicine.medical_specialty
Volume overload
Angiotensin-Converting Enzyme Inhibitors
Cardiomegaly
Losartan
Rats, Sprague-Dawley
Renin-Angiotensin System
Random Allocation
Enalapril
Internal medicine
Renin–angiotensin system
medicine
Animals
Pharmacology (medical)
Aorta, Abdominal
Heart Failure
Pharmacology
Analysis of Variance
Mitogen-Activated Protein Kinase 3
Kinase
business.industry
Hemodynamics
medicine.disease
Rats
Blockade
Endocrinology
Heart failure
Drug Therapy, Combination
Mitogen-Activated Protein Kinases
Cardiology and Cardiovascular Medicine
business
Angiotensin II Type 1 Receptor Blockers
medicine.drug
Subjects
Details
- ISSN :
- 19404034 and 10742484
- Volume :
- 15
- Database :
- OpenAIRE
- Journal :
- Journal of Cardiovascular Pharmacology and Therapeutics
- Accession number :
- edsair.doi.dedup.....d68517e86d3b361b25841f75f63d6040
- Full Text :
- https://doi.org/10.1177/1074248409356430